Flex Labs Inc. Director / PDMR Shareholding
March 08 2024 - 2:00AM
RNS Regulatory News
RNS Number : 0711G
Flex Labs Inc.
08 March 2024
8 March 2024
Flex Labs Inc
("Flex Labs" or the "Company")
Director / PDMR
Shareholding
Flex Labs (AQSE: FLEX) announces
that it has been notified of the following transactions in ordinary
shares in the Company undertaken by a person closely associated
with Mike Edwards (Executive Chairman), details of which are set
out in the notification below.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Supernova Digital Assets
PLC
|
|
2.
|
Reason for the Notification
|
|
a)
|
Position/status
|
PCA to a PDMR (Mike Edwards,
Executive Chairman)
|
|
b)
|
Initial notification /
Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Flex Labs Inc
|
|
b)
|
LEI
|
98450075C56BCFB38260
|
|
4.
|
Details of the transaction(s):
section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
|
a)
|
Description of the Financial
instrument, type of instrument
|
Ordinary Shares
|
|
|
Identification Code
|
CA33939R1073
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
GBP 0.0655 per Ordinary Share
GBP 0.065 per Ordinary Share
GBP 0.066 per Ordinary Share
GBP 0.0665 per Ordinary Share
GBP 0.065 per Ordinary Share
|
500,000 Ordinary Shares (27 February
2024)
25,000 Ordinary Shares (8 February
2024)
137,500 Ordinary Shares (18 January
2024)
400,000 Ordinary Shares (10 January
2024)
175,000 Ordinary Shares
(27 December 2023)
|
|
|
|
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
1,237,500 Ordinary
Shares
£81,425
|
|
e)
|
Date of the transaction
|
27 December 2023; 10 and 18 January
2024; 8 and 27 February 2024
|
|
f)
|
Place of the Transaction
|
Aquis Stock Exchange
|
The directors of Flex Labs Inc accept
responsibility for this announcement.
For further information please
contact:
|
Flex Labs
Inc
|
|
Michael Edwards
|
Via First Sentinel
|
|
First Sentinel
(Corporate
Adviser)
|
|
Brian Stockbridge
|
brian@first-sentinel.com
+44 (0) 20 3855 5551
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXQKOBPOBKDQNK
Flex Labs (AQSE:FLEX)
Historical Stock Chart
From Apr 2024 to May 2024
Flex Labs (AQSE:FLEX)
Historical Stock Chart
From May 2023 to May 2024
